Precipio reports mixed financial results in latest earnings. The diagnostic company posted a full-year GAAP loss per share of negative $0.23, indicating the firm remains unprofitable on a net basis. However, revenue growth tells a different story, with annual sales reaching $24.05 million, representing a robust 29.8 percent increase year-over-year. This strong top-line growth suggests Precipio is successfully expanding its market presence and customer base despite current profitability challenges. The significant revenue acceleration demonstrates demand for the company's diagnostic solutions. Investors will be watching closely to see if management can convert this growing revenue into profitability in coming periods.
Post from MarketNews_en
Log in to interact with content.